Início/Ações/AURA

AURA

USD

Aura Biosciences Inc. Common Stock

$5.680-0.270 (-4.538%)

Preço em tempo real

Healthcare

Biotecnologia

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$5.950

Máximo

$5.960

Mínimo

$5.630

Volume

0.05M

Fundamentos da empresa

Capitalização de mercado

352.8M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.24M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $4.345Atual $5.680Máximo $11.29

Relatório de análise de IA

Última atualização: 3/11/2025

Gerado por IAFonte de dados: Yahoo Finance, Bloomberg, SEC

AURA Biosciences (AURA): Mixed Signals Near $6.10 Support Level

News Sentiment: Positive Catalysts Without Market Conviction

Aura Biosciences received two bullish signals from analysts and corporate events:

H.C. Wainwright Conference Participation (Sep 3): Failed to generate immediate momentum despite potential for investor visibility.
Analyst Buy Rating (Aug 13): Maintained a $22 price target--360% above current prices--but the stock hasn’t responded.

Market reaction to news appears muted. While analyst commentary remains optimistic, shares have traded flat-to

Notícias relacionadas

3/09/2025 · 11:00

GlobeNewswire

Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function,

Ver mais